Tesamorelin 5 mg/Ipamorelin 5 mg

Peptide Hubs Tesamorelin/Ipamorelin 10mg: The Precision Engine for Visceral Fat Loss

For bodybuilders and athletes pushing for that final level of conditioning, not all fat is created equal. Subcutaneous fat is visible, but visceral fat—the dangerous adipose tissue stored deep within the abdominal cavity—is often the most stubborn to lose and the most detrimental to both health and a truly shredded physique. Peptide Hubs Tesamorelin 5 mg/Ipamorelin 5 mg represents a targeted evolutionary step in peptide therapy. This powerful pre-blended stack combines the unique, clinically-proven visceral fat-reducing properties of Tesamorelin with the clean, potent pulse of Ipamorelin. Unlike generic GH-releasing stacks, this blend is specifically engineered to reshape your midsection, carving out a defined, vascular core by targeting the fat that matters most, while simultaneously providing all the systemic benefits of elevated Growth Hormone.

Targeted Effects for Ultimate Conditioning

This blend leverages the unique strengths of both peptides to create a powerful, targeted effect. Tesamorelin is a Growth Hormone-Releasing Hormone (GHRH) analog specifically studied and approved for reducing excess visceral abdominal fat. Ipamorelin is a selective Growth Hormone-Releasing Peptide (GHRP) that provides a strong GH pulse without unwanted side effects. Together, they offer a distinct advantage:

• Preferential Visceral Fat Reduction: Tesamorelin has a demonstrated clinical preference for reducing deep abdominal fat, helping to unveil a tighter, more defined midsection and potentially improving insulin sensitivity.
• Powerful Synergistic GH Release: The combination creates a robust pulse of Growth Hormone, supporting overall fat loss, muscle preservation, and enhanced recovery.
• Improved Lipid Profiles: Users often experience positive changes in cholesterol levels, supporting cardiovascular health during intense dieting phases.
• Enhanced Skin Tightening and Quality: The increased GH and IGF-1 from the stack promotes collagen synthesis, which can improve skin elasticity—a critical benefit when achieving very low body fat levels.
• Clean Profile with No Hunger Stimulation: Thanks to Ipamorelin's selectivity, this stack provides powerful effects without the intense hunger associated with GHRP-6, making it ideal for contest preparation.

The clinical profile of Tesamorelin is well-established, confirming its specific action on visceral adipose tissue.

Optimal Dosage and Administration Protocol

This product is supplied as a 10mg lyophilized powder blend (5mg Tesamorelin + 5mg Ipamorelin) in a sterile 2mL vial. Reconstitute with Bacteriostatic Water.

Reconstitution Example: Adding 2mL of diluent creates a concentration of 5mg/mL total peptide, meaning each 1mL (100 unit mark on an insulin syringe) contains 2.5mg of Tesamorelin and 2.5mg of Ipamorelin.

Standard Dosing Protocol:

• Common Effective Dose: 1 mg (1000 mcg) of the total blend per injection. This provides 500 mcg of Tesamorelin and 500 mcg of Ipamorelin.
• Frequency: Once daily, administered at bedtime. This timing leverages the body's natural nocturnal GH surge and is the standard protocol for Tesamorelin's efficacy.
• Cycle Length: 12-24 weeks. Due to the specific and sustained action of Tesamorelin, longer cycles are common and highly effective for achieving significant visceral fat loss.

Injections are performed subcutaneously, typically in the abdominal fat, and must be administered on an empty stomach. Avoid food for at least 2 hours before and 30 minutes after injection to ensure an unblunted GH response.

Strategic Implementation for Cutting and Recomposition

The Peptide Hubs Tesamorelin/Ipamorelin blend is the cornerstone of an advanced cutting or recomposition protocol. Its targeted action makes it incredibly valuable when stacked with other compounds to maximize fat loss and preserve muscle.

• The Ultimate Visceral Fat Attack Stack: Combine with the powerful fat-burner Adipotide (FTPP), which targets the blood supply to white adipose tissue, for a multi-faceted assault on stubborn fat deposits.
• For Enhanced Metabolic Rate: Stack with AICAR 50 mg to activate the AMPK pathway, improving endurance and fat oxidation during fasted cardio, synergizing with the metabolic benefits of the peptide blend.
• With Healing and Recovery Support: Add BPC 157 to your regimen to support gut health and systemic repair, which can be challenged during intense cutting phases and caloric restriction.
• For Cognitive Function on a Calorie Deficit: Pair with N-Acetyl Semax Amidate to maintain sharp mental focus, elevated mood, and cognitive resilience while dieting.
• During Post-Cycle Therapy (PCT): Use this blend alongside Sermorelin to maintain an anabolic environment and prevent the accumulation of visceral fat that commonly occurs when coming off cycle, helping you keep your hard-earned conditioning.

Possible Side Effects and Safety Considerations

This blend is generally very well-tolerated, with a side effect profile similar to other GHRH/GHRP stacks. Most side effects are mild and transient:

• Transient Flushing or Tingling: A brief, mild warmth or tingling sensation may occur post-injection, typically subsiding within 30 minutes.
• Mild Joint Discomfort: Some users report temporary joint stiffness or fluid retention, a common sign of increased GH activity, which usually resolves as the body adapts.
• Injection Site Reactions: Minor redness, itching, or pain at the injection site may occur but is rare with proper technique.
• Blood Glucose Changes: As with any GH-affecting compound, transient impacts on blood sugar can occur. Diabetics should monitor their levels closely.
• Increased Appetite: Unlike GHRP-6, Ipamorelin typically does not cause significant hunger, but a slight increase in appetite is possible for some users.

Contraindications include a known sensitivity to GH-releasing hormones. There is no known liver toxicity or HPTA suppression associated with this blend.

Lab-Verified Potency for Guaranteed Results

The specificity of Tesamorelin's action means that underdosed or impure products will fail to deliver the targeted visceral fat loss that is this stack's primary advantage. Peptide Hubs ensures quality through independent third-party testing. The lab report for this batch confirms a total content of 9.79 mg of active peptide, representing a 97.9% purity level. This verification provides confidence that you are receiving a high-integrity product where both the Tesamorelin and Ipamorelin are fully potent and present in the correct ratio, ensuring you experience the powerful, targeted fat loss and synergistic GH effects that this advanced stack is designed to deliver.

Tesamorelin/Ipamorelin Profile

Name: Tesamorelin and Ipamorelin Blend
Drug Class: Growth Hormone Secretagogue (GHRH Analog + GHRP)
Other common names and terms: Egrifta (Tesamorelin brand) & Ipamorelin Stack
Active Life: Tesamorelin: ~30 min (effects prolonged); Ipamorelin: ~2 hours
Detection Time: Not applicable for standard athletic testing
Chemical Structure: Tesamorelin (44-amino acid analog of GHRH), Ipamorelin (Pentapeptide)
Common Doses: 500-1000 mcg of each peptide, typically once daily
Blood pressure: No negative effect; may have a positive regulatory effect
Acne: Rare, due to increased IGF-1
Water retention: Minimal, transient water retention possible
Aromatisation: Does not aromatize
Liver toxicity: Not hepatotoxic
Decrease HPTA function: Does not suppress the HPTA axis

Third Party Lab Test Results

2025-09-29

View Result

9.79 mg